Literature DB >> 12787070

Functional consequences of homo- but not hetero-oligomerization between transporters for the biogenic amine neurotransmitters.

A M Kocabas1, G Rudnick, F Kilic.   

Abstract

Before this study, the human norepinephrine transporter (hNET) was the only member of the biogenic amine neurotransmitter transporter family that had not been demonstrated to be a functional homo-oligomer. Here, using two forms of the transporter, I155C and hNET-myc, with distinct antigenicity and inhibitor sensitivity, we demonstrated that hNET exists as a homo-oligomer. hNET I155C is a functional mutant and is sensitive to inactivation by the sulfhydryl reagent [2-(trimethylammonium)ethyl]methanethiosulfonate, while hNET-myc is resistant to inactivation by this reagent. Coimmunoprecipitation of these two forms demonstrated that a physical interaction exists between norepinephrine transporter monomers. Further characterization of this physical interaction has revealed that the activity of norepinephrine transporters depends on interactions between monomers. Because norepinephrine transporters and serotonin transporters are the only two members of the neurotransmitter transporter family endogenously expressed in the cell membrane of the same cells, placental syncytiotrophoblasts, we tested the ability of norepinephrine transporters and serotonin transporters to associate and function in a hetero-oligomeric form. Similarly, coexpression of hNET-myc with serotonin transporter-FLAG showed a physical interaction in coimmunoprecipitation assays. However, coexpression of serotonin and norepinephrine transporters did not sensitize norepinephrine transporter activity to inhibition by citalopram, a selective serotonin transport inhibitor. Thus, the norepinephrine transporter-serotonin transporter physical association did not produce functional consequences. Based on this, we propose that the transporters for biogenic amine neurotransmitters interact functionally in homo- but not hetero-oligomeric forms.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12787070      PMCID: PMC3039113          DOI: 10.1046/j.1471-4159.2003.01793.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  34 in total

1.  Immunolocalization of the cocaine- and antidepressant-sensitive l-norepinephrine transporter.

Authors:  S Schroeter; S Apparsundaram; R G Wiley; L H Miner; S R Sesack; R D Blakely
Journal:  J Comp Neurol       Date:  2000-05-01       Impact factor: 3.215

2.  Permeation and gating residues in serotonin transporter.

Authors:  J G Chen; G Rudnick
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Symmetrical dimer of the human dopamine transporter revealed by cross-linking Cys-306 at the extracellular end of the sixth transmembrane segment.

Authors:  H Hastrup; A Karlin; J A Javitch
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-28       Impact factor: 11.205

5.  Oligomerization and trafficking of the human dopamine transporter. Mutational analysis identifies critical domains important for the functional expression of the transporter.

Authors:  Gonzalo E Torres; Ana Carneiro; Katie Seamans; Chiara Fiorentini; Ava Sweeney; Wei-Dong Yao; Marc G Caron
Journal:  J Biol Chem       Date:  2002-11-11       Impact factor: 5.157

6.  Oligomerization of the human serotonin transporter and of the rat GABA transporter 1 visualized by fluorescence resonance energy transfer microscopy in living cells.

Authors:  J A Schmid; P Scholze; O Kudlacek; M Freissmuth; E A Singer; H H Sitte
Journal:  J Biol Chem       Date:  2000-11-08       Impact factor: 5.157

Review 7.  Differential effects of stimulants on monoaminergic transporters: pharmacological consequences and implications for neurotoxicity.

Authors:  A E Fleckenstein; J W Gibb; G R Hanson
Journal:  Eur J Pharmacol       Date:  2000-10-06       Impact factor: 4.432

8.  Determinants within the C-terminus of the human norepinephrine transporter dictate transporter trafficking, stability, and activity.

Authors:  Patricia A Bauman; Randy D Blakely
Journal:  Arch Biochem Biophys       Date:  2002-08-01       Impact factor: 4.013

9.  Accessibility and conformational coupling in serotonin transporter predicted internal domains.

Authors:  Andreas Androutsellis-Theotokis; Gary Rudnick
Journal:  J Neurosci       Date:  2002-10-01       Impact factor: 6.167

10.  Oligomerization of serotonin transporter and its functional consequences.

Authors:  F Kilic; G Rudnick
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

View more
  20 in total

Review 1.  Molecular mechanisms of SERT in platelets: regulation of plasma serotonin levels.

Authors:  Charles P Mercado; Fusun Kilic
Journal:  Mol Interv       Date:  2010-08

2.  Discrepancy in Insulin Regulation between Gestational Diabetes Mellitus (GDM) Platelets and Placenta.

Authors:  Yicong Li; Anthonya Cooper; Imelda N Odibo; Asli Ahmed; Pamela Murphy; Ruston Koonce; Nafisa K Dajani; Curtis L Lowery; Drucilla J Roberts; Luc Maroteaux; Fusun Kilic
Journal:  J Biol Chem       Date:  2016-02-26       Impact factor: 5.157

3.  Dopamine transporter oligomerization: impact of combining protomers with differential cocaine analog binding affinities.

Authors:  Juan Zhen; Tamara Antonio; Shu-Yuan Cheng; Solav Ali; Kymry T Jones; Maarten E A Reith
Journal:  J Neurochem       Date:  2015-01-26       Impact factor: 5.372

4.  Functional properties of dopamine transporter oligomers after copper linking.

Authors:  Juan Zhen; Maarten E A Reith
Journal:  J Neurochem       Date:  2017-12-21       Impact factor: 5.372

5.  Organic cation transporter 3 contributes to norepinephrine uptake into perivascular adipose tissue.

Authors:  Nadia Ayala-Lopez; William F Jackson; Robert Burnett; James N Wilson; Janice M Thompson; Stephanie W Watts
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-10-02       Impact factor: 4.733

Review 6.  Regulation of monoamine transporters and receptors by lipid microdomains: implications for depression.

Authors:  Joanne J Liu; Adrienne Hezghia; Saame Raza Shaikh; Joshua F Cenido; Ruth E Stark; J John Mann; M Elizabeth Sublette
Journal:  Neuropsychopharmacology       Date:  2018-06-28       Impact factor: 7.853

7.  Expression and function of variants of human catecholamine transporters lacking the fifth transmembrane region encoded by exon 6.

Authors:  Chiharu Sogawa; Chieko Mitsuhata; Kei Kumagai-Morioka; Norio Sogawa; Kazumi Ohyama; Katsuya Morita; Katsuyuki Kozai; Toshihiro Dohi; Shigeo Kitayama
Journal:  PLoS One       Date:  2010-08-05       Impact factor: 3.240

8.  Substrate binding and formation of an occluded state in the leucine transporter.

Authors:  Leyla Celik; Birgit Schiøtt; Emad Tajkhorshid
Journal:  Biophys J       Date:  2007-11-16       Impact factor: 4.033

9.  Glycosyl modification facilitates homo- and hetero-oligomerization of the serotonin transporter. A specific role for sialic acid residues.

Authors:  Deniz Ozaslan; Sophie Wang; Billow A Ahmed; Arif M Kocabas; John C McCastlain; Anca Bene; Fusun Kilic
Journal:  J Biol Chem       Date:  2003-08-27       Impact factor: 5.157

Review 10.  The reverse operation of Na(+)/Cl(-)-coupled neurotransmitter transporters--why amphetamines take two to tango.

Authors:  Harald H Sitte; Michael Freissmuth
Journal:  J Neurochem       Date:  2009-11-05       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.